151 research outputs found

    A proof of the S-genus identities for ternary quadratic forms

    Full text link
    In this paper we prove the main conjectures of Berkovich and Jagy about weighted averages of representation numbers over an S-genus of ternary lattices (defined below) for any odd squarefree S \in N. We do this by reformulating them in terms of local quantities using the Siegel-Weil and Conway-Sloane formulas, and then proving the necessary local identities. We conclude by conjecturing generalized formulas valid over certain totally real number fields as a direction for future work.Comment: 14 page

    On the cohomology of linear groups over imaginary quadratic fields

    Full text link
    Let Gamma be the group GL_N (OO_D), where OO_D is the ring of integers in the imaginary quadratic field with discriminant D<0. In this paper we investigate the cohomology of Gamma for N=3,4 and for a selection of discriminants: D >= -24 when N=3, and D=-3,-4 when N=4. In particular we compute the integral cohomology of Gamma up to p-power torsion for small primes p. Our main tool is the polyhedral reduction theory for Gamma developed by Ash and Koecher. Our results extend work of Staffeldt, who treated the case n=3, D=-4. In a sequel to this paper, we will apply some of these results to the computations with the K-groups K_4 (OO_{D}), when D=-3,-4

    On the cohomology of GL_2 and SL_2 over imaginary quadratic fields

    Full text link
    We report on computations of the cohomology of GL_2(O_D) and SL_2(O_D), where D<0 is a fundamental discriminant. These computations go well beyond earlier results of Vogtmann and Scheutzow. We use the technique of homology of Voronoi complexes, and our computations recover the integral cohomology away from the primes 2, 3. We observed exponential growth in the torsion subgroup of H^2 as DD increases, and compared our data to bounds of Rohlfs

    Choosing the right model for unified flexibility modeling

    Get PDF
    Using aggregated flexibility from distributed small-scale power devices is an extensively discussed approach to meet the challenges in modern and increasingly stochastic energy systems. It is crucial to be able to model and map the flexibility of the respective power devices in a unified form to increase the value of the cumulative flexibility from different small-scale power devices by aggregation. In order to identify the most suitable approach for unified flexibility modeling we present a framework to evaluate and compare the advantages and disadvantages of already existing modeling approaches in different levels of detail. As an introduction to flexibility modeling and as a basis for the evaluation process we initially provide a comprehensive overview of the broad range of flexibility models described in scientific literature. Subsequently, five selected modeling approaches allowing the generation of a unified flexibility representation for different power devices are presented in detail. By using an evaluation metric we assess the suitability of the selected approaches for unified flexibility modeling and their applicability. To allow a more detailed performance analysis, the best evaluated models are implemented and simulations with different small-scale devices are performed. The results shown in this paper highlight the heterogeneity of modeling concepts deriving from the various interpretations of flexibility in scientific literature. Due to the varying complexity of the modeling approaches, different flexibility potentials are identified, necessitating a combination of approaches to capture the entire spectrum of the flexibility of different small-scale power devices. Furthermore, it is demonstrated that a complex model does not necessarily lead to the discovery of higher flexibility potentials, and recommendations are given on how to choose an appropriate model. © 2022, The Author(s)

    Development of Pan-filovirus vaccine against Ebola and Marburg virus challenges

    Get PDF
    Filoviruses such as Ebola (EBOV) and Marburg (MARV) viruses cause deadly viral hemorrhagic fever in humans with high case fatality rates. To date, no licenced therapeutic or vaccine has been clinically approved to prevent infection. Several vaccine candidates are under development against the few most common filoviruses targeting the virus glycoprotein (GP). However, protective antibodies induced by such GP vaccines are usually limited to the same species. In contrast, T-cell vaccines offer an opportunity to design a single pan-filovirus vaccine protecting against all members of the Filoviridae family. In this study FILOcepX vaccines were constructed targeting the four most conserved regions among the viral proteomes with the aim to induce protective T-cell responses against different filoviruses. BALB/c mice were immunized with FILOcep 1 and 2 vaccines vectored by non-replicating engineered simian adenovirus and poxvirus MVA. Groups of 20 BALB/c mice were primed and boosted with either the FILOcep1 and FILOcep2 vaccines or control ChAdOx1- and MVA-vectored vaccines. Four animals in each group were sacrificed after 1 week of boosting to detect T-cell response for the FILOcepX antigen. High frequency T cells specific responses were detected in mice receiving the test vaccines by IFN-γ ELISPOT kits. Of the remaining 16 animals in each group, 8 were challenged with mouse-adapted EBOV and 8 were challenged with mouse adapted MARV in Containment Level 4 laboratory. All the mice in the control group either died or had to be euthanized between 4 and 6 days post challenge. On the other hand all the FILOcepX vaccinated mice maintained their normal body mass and survived till the end of the scheduled protocol on day 29 post challenge. These FILOcepX vaccines provided 100% protection against the lethal challenges with filoviruses of two different genera. Further evaluation the efficacy of this vaccine in non-human primates (NHPs) is warranted

    Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia

    Get PDF
    © 2008 Henry et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
    corecore